Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
Katarzyna Korzeniowska, Jerzy Jankowski, Artur Cieślewicz, Anna Jabłecka Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznan 61-848, PolandCorrespondence: Artur CieślewiczDepartment of Clinical Pharmacology, Poznan University of Medical Sciences, Długa 1/2 Str., Poznan...
Saved in:
Main Authors: | Korzeniowska K, Jankowski J, Cieślewicz A, Jabłecka A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f80b7307cee940139e2c39ff4c6ac18d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología
by: Hameau,René, et al.
Published: (2018) -
European journal of heart failure. journal of the Working Group on Heart Failure of the European Society of Cardiology.
Published: (2002) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
by: Sousa,MG, et al.
Published: (2014) -
European journal of heart failure
Published: (1999) -
Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
by: Amy Hyein Kim, et al.
Published: (2022)